Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

Tecan Journal

Selected category: FluentControl

Back to overview

Streamlining Workflows For Australia’s Largest Pathology Provider

Pathology is at the core of diagnostics, and obtaining reliable and timely results requires quick and accurate liquid handling. With laboratories often being pushed to their limits, automation can lend a helping hand and provide the ability to adapt to sudden workload increases. The R&D team at Sullivan Nicolaides Pathology is developing streamlined solutions to help its laboratories increase their throughput, and free up staff from tedious and error prone tasks. This includes creating new automation scripts to optimize existing diagnostics workflows, as well as designing new hardware to expand the range of pathology applications that are compatible with existing liquid handling platforms.

Read more

Non-invasive screening tests for preventive healthcare

Aqsens Health is focused on developing non-invasive screening and diagnostic tests based on enhanced time-resolved fluorescence for health monitoring and detection of serious diseases, such as cancer, where early diagnosis is vital. With an increasing workload, the company has turned to automation to allow higher throughput and rapid delivery of high quality results.

Read more

A sensitive subject

Determining if a new cosmetic product, pharmaceutical ingredient or chemical substance is harmful to humans is a key prerequisite for product safety and consumer protection. Traditionally, skin sensitization testing relied on animal models, but these approaches are expensive, time consuming and raise ethical questions, while only offering limited human relevance and accuracy. SenzaGen has developed a unique, in vitro approach to sensitization testing, combining cell biology and flow cytometry with genomics-based screening and machine learning-assisted classifications.

Read more

A smooth path for novel biologics

Cell culture is at the heart of the production process for many biopharmaceuticals, but finding the optimal conditions to maximize yield can be a complex and time-consuming process. Traditional process development relies on costly and labor-intensive set-ups, significantly limiting throughput and the range of experimental conditions that can be assessed. Scientists in Roche Pharma Research and Early Development (pRED) have adopted an alternative approach, combining single-use microbioreactors with advanced automation and analytical platforms to streamline the workflow.

Read more

Taking a Fluent® approach to genetic screening

Clinical diagnostics company Ambry Genetics focuses on the identification of germline mutations, detecting large deletions and duplications primarily by next generation sequencing. Automation holds the key to efficient high throughput assays, ensuring optimum productivity.

Read more

Stem cell research offers muscular dystrophy hope

Access to human pluripotent embryonic stem cells is enabling Genea Biocells to pioneer novel therapies to treat a number of neuromuscular diseases. Drawing on almost 30 years of research heritage, the company is using its expertise to model spinal muscular atrophy and facioscapulohumeral muscular dystrophy to identify potential therapies.

Read more